FDA Inspection 1304554 — Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H.

Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. — FEI 3008853092

The FDA completed an inspection of Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. on May 15, 2025 in Tornesch. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 15, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tornesch (Germany)

Additional Details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.